Sharechat Logo

Daily ShareChat: Comvita

By Jenny Ruth

Friday 7th May 2010

Text too small?
 Jenny Ruth

Honey-based products company Comvita unaudited sales, profit and net debt results for the year ended March are significantly better than its 2009 results and, while sales are as he forecast, the net profit and net debt are significantly better than his forecast, says Selwyn Blinkhorne, an analyst at Craigs Investment Partners.

Comvita said sales are up 19% to $85 million, net profit is $4.9 million compared with $761,000 the previous year and net debt fell to $11.6 million from $30.3 million a year earlier. Blinkhorne had expected a $4.2 million net profit and net debt of $23.8 million.

"Comvita states the result reflects a continuing strong trend in sales growth and overall operating efficiencies with lower inventories, global licensing rights proceeds and improved operating performance resulting in lower debt levels," Blinkhorne says.

"The potential of the $50 million of acquisitions in 2008 is now being realised," he says. The company bought Olive Products Australia, its Hong Kong distributor and New Zealand's leading medical honey producer that financial year.

"We have increased our earnings forecasts 12% to 16%, mainly attributable to lower interest costs on lower debt levels and increased our dividend forecasts by around 1.5 cents per share, with a consistent 40% payout," he says.




(Note:  Neil Craig is chairman of Comvita and Craigs Investment Partners).



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Comvita may not increase earnings in 2014 as higher honey prices bite, Craigs says
Comvita turned to a loss in first half, remains confident of increasing annual profit
Nasdaq-listed Derma Sciences takes 7.3 percent stake in Comvita in discounted placement
Comvita FY profit falls 10 percent , beating guidance, on honey shortage, rising costs
Comvita flags 15 percent fall in FY profit as expensive honey, supply shortages prompt downgrade
Comvita buys Aussie groves to expand olive extract output
Comvita first-half earnings fall 7.4% amid short supply
Comvita buys Whanganui-based Kiwi Honey for undisclosed sum
Comvita hits 5-yr high on early results from diabetes trial
Comvita to seek deeper pool for directors' fees at AGM